Effect of moringa leaves powder on body weight, glycemic status, lipid profile, and blood pressure in overweight individuals with hyperlipidemia

被引:0
作者
Munir, Maria [1 ]
Khan, Imran [2 ]
Almutairi, Nayef Shabbab [3 ]
Almutairi, Aeshah Hamdan [3 ]
Khan, Bilal [1 ]
Mehboob, Najma [1 ]
机构
[1] Univ Agr Peshawar, Fac Nutr Sci, Dept Human Nutr, Peshawar, Pakistan
[2] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Food Sci & Nutr, Muscat 123, Oman
[3] Umm Al Qura Univ, Al Leith Coll Hlth Sci, Dept Publ Hlth, Mecca, Saudi Arabia
关键词
Cholesterol; BMI; Sphygmomanometer; HDL; Triglycerides; DIETARY-FAT; OLEIFERA;
D O I
10.15586/ijfs.v37i1.2744
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Moringa leaf powder has demonstrated beneficial effects on body weight, lipid profiles,and blood pressure in animal studies. However, research on the impact of moringa on theseparameters in humans is limited. Therefore, the aim of this study was to examinethe effects of moringa on body weight, glycemic status, lipid profile, and blood pressure inhuman subjects. The study was designed as a randomized controlled parallel clinical trial. A total of 40 overweight, hyperlipidemic subjects (both sexes), aged 30 to 60 years, wereincluded. Participants were assigned to either the moringa group (n=20) or the control group. The moringa groupreceived capsules containing 0.5 g of powdered moringa leaves, while the control groupreceived capsules containing 0.5 g of corn starch, both administered twice a day for 12 weeks. Additionally, bothgroups were instructed to engage in moderate-intensity physical activity for 40 to 60 minutes. Anthropometric measurements, including weight,BMI, and waist circumference, were taken at baseline and after 12 weeks of intervention. Dietary intake wasassessed using the 24-hour dietary recall method at baseline and at the end of the intervention. Venous blood (5 ml) was collected at both time points to determine biochemical parameters, including lipidprofile and blood glucose levels. Blood pressurewas measured with a sphygmomanometer at baseline and after 12 weeks of intervention. Thefindings revealed a significant reduction in carbohydrate, energy, and cholesterol intake inthe moringa group compared to baseline values. Body weight, BMI, and waist circumference (WC) weresignificantly lower (P <= 0.05) in the treatment group than in the control group. Additionally, there weresignificant differences (P <= 0.05) in blood pressure, triglyceride levels, and LDL and HDL cholesterol levelsbetween the treatment and control groups. The findings of this study indicated that a 1 g doseof moringa over 12 weeks effectively reduced body weight, blood pressure, triglycerides,and LDL and HDL cholesterol levels, while a nonsignificant reduction in total cholesterol was observed inoverweight subjects with hyperlipidemia. Therefore, moringa may serve as a complementarytreatment alongside existing therapies to improve lipid profiles in hyperlipidemic patients.
引用
收藏
页码:210 / 219
页数:10
相关论文
共 35 条
  • [31] The Automated Self-Administered 24-Hour Dietary Recall (ASA24): A Resource for Researchers, Clinicians, and Educators from the National Cancer Institute
    Subar, Amy F.
    Kirkpatrick, Sharon I.
    Mittl, Beth
    Zimmerman, Thea Palmer
    Thompson, Frances E.
    Bingley, Christopher
    Willis, Gordon
    Islam, Noemi G.
    Baranowski, Tom
    McNutt, Suzanne
    Potischman, Nancy
    [J]. JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2012, 112 (08) : 1134 - 1137
  • [32] Consumption of Moringa oleifera Lam Leaves Lowers Postprandial Blood Pressure
    Sun, Marie Chan
    Ruhomally, Zaina B.
    Boojhawon, Ravindra
    Neergheen-Bhujun, Vidushi S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2020, 39 (01) : 54 - 62
  • [33] Dietary fat intake as risk factor for the development of diabetes - Multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD)
    Thanopoulou, AC
    Karamanos, BG
    Angelico, FV
    Assaad-Khalil, SH
    Barbato, AF
    Del Ben, MP
    Djordjevic, PB
    Dimitrijevic-Sreckovic, VS
    Gallotti, CA
    Katsilambros, NL
    Migdalis, IN
    Mrabet, MM
    Petkova, MK
    Roussi, DP
    Tenconi, MTP
    [J]. DIABETES CARE, 2003, 26 (02) : 302 - 307
  • [34] MEASURING CYTOKINE LEVELS IN BLOOD - IMPORTANCE OF ANTICOAGULANTS, PROCESSING, AND STORAGE-CONDITIONS
    THAVASU, PW
    LONGHURST, S
    JOEL, SP
    SLEVIN, ML
    BALKWILL, FR
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 153 (1-2) : 115 - 124
  • [35] Viet L., 2008, The feasibility of a European Health Examination Survey (FEHES) recommendations